Fenfluramine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3805 publications

Characterizing SCN1A-Related Disorders Using Real-World Data Across 681 Patient-Years.

Characterizing SCN1A-Related Disorders Using Real-World Data Across 681 Patient-Years.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

Recent advances in PET measures of brain 5-HT release.

Recent advances in PET measures of brain 5-HT release.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: March 19, 2026

Practical Recommendations for Cardiology Follow-Up in Patients Treated with Fenfluramine Based on Expert Opinion and Clinical Experience.

Practical Recommendations for Cardiology Follow-Up in Patients Treated with Fenfluramine Based on Expert Opinion and Clinical Experience.

Journal: Neurology and therapy

Published: February 13, 2026

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

Journal: Journal of child neurology

Published: January 21, 2026

Fenfluramine for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome.

Fenfluramine for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome.

Journal: Australian prescriber

Published: December 19, 2025

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Journal: The Annals of pharmacotherapy

Published: December 01, 2025

Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance Database.

Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance Database.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 22, 2025

Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approach.

Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approach.

Journal: Epilepsia open

Published: November 21, 2025

A meta-analysis of efficacy and safety of anti-obesity medications in the treatment of childhood obesity

A meta-analysis of efficacy and safety of anti-obesity medications in the treatment of childhood obesity

Journal: Zhonghua yi xue za zhi

Published: November 11, 2025

From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders.

From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders.

Journal: International journal of molecular sciences

Published: November 07, 2025

Use of fenfluramine in MECP2-related Rett syndrome: Findings from a retrospective multicenter pediatric case series.

Use of fenfluramine in MECP2-related Rett syndrome: Findings from a retrospective multicenter pediatric case series.

Journal: Epilepsy & behavior : E&B

Published: October 29, 2025

Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration.

Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration.

Journal: JAMA ophthalmology

Published: October 23, 2025

Showing 1-12 of 3,805

Last Updated: 04/28/2026